+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Phase 3
Age: 18Years +
All Genders
ID07064954

Evaluating Autologous Cold-Stored Platelets Collected Before Elective Complex Cardiac Surgery to Reduce Allogeneic Transfusions A Randomized Patient Preference Trial

Led by University Health Network, Toronto · Updated on 2026-10-05

100

Participants Needed

1

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of autologous cold-stored apheresis platelets collected 7 to 10 days before elective complex cardiac surgery to see if this approach can reduce the need for allogeneic platelet transfusions. This randomized patient preference trial aims to improve patient outcomes and lessen the demand on allogeneic platelet supplies by offering patients the option to donate their own platelets ahead of surgery. The study is being conducted at Toronto General Hospital with support from the University Health Network, Toronto. Participants are assigned to one of two groups. The intervention group donates two units of their own platelets via apheresis about a week before surgery these platelets are then cold-stored at 1-6C until needed during or after surgery for managing bleeding related to low platelet count or function. The control group receives standard allogeneic platelets supplied by Canadian Blood Services, stored at room temperature for up to 7 days, during or after surgery as needed. If more platelet doses are required beyond the first two within 24 hours after cardiopulmonary bypass, all participants receive standard allogeneic platelets. Participants will be monitored for platelet transfusions up to 24 hours after cardiopulmonary bypass ends. The study tracks the effectiveness of autologous platelets in avoiding allogeneic transfusions and assesses patient willingness to donate platelets before surgery. Safety monitoring includes assessing platelet counts and bleeding outcomes. The trial is expected to run from late 2026 through early 2028, with participant involvement spanning from pre-surgery donation through surgery and immediate recovery.

CONDITIONS

Brief Title

Autologous Cold-stored Apheresis Platelets

Research Team

K

Keyvan Karkouti, MD

D

Deep Grewal

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here